These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23494466)

  • 21. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review.
    Hassali MA; Wong ZY; Alrasheedy AA; Saleem F; Mohamad Yahaya AH; Aljadhey H
    Health Policy; 2014 Sep; 117(3):297-310. PubMed ID: 25129135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost containment and the profit motive.
    Joseph BS
    Am J Psychiatry; 1993 Sep; 150(9):1433-4. PubMed ID: 8352367
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of drug samples on prescribing to the uninsured.
    Miller DP; Mansfield RJ; Woods JB; Wofford JL; Moran WP
    South Med J; 2008 Sep; 101(9):888-93. PubMed ID: 18708971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The General Medical Council and doctors' financial interests.
    Adlington K; Abbasi K; Godlee F
    BMJ; 2015 Jan; 350():h474. PubMed ID: 25630755
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
    Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
    Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physician drug dispensing in Switzerland: association on health care expenditures and utilization.
    Trottmann M; Frueh M; Telser H; Reich O
    BMC Health Serv Res; 2016 Jul; 16():238. PubMed ID: 27391118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Policies and perceptions on generic drugs: The case of Greece.
    Xanthopoulou SS; Katsaliaki K
    Health Serv Manage Res; 2019 Feb; 32(1):49-56. PubMed ID: 29376411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge and attitudes of physicians and pharmacists towards the use of generic medicines in Bosnia and Herzegovina.
    Čatić T; Avdagić L; Martinović I
    Med Glas (Zenica); 2017 Feb; 14(1):25-32. PubMed ID: 27917846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A piece of my mind. Slippery slopes and landing on your feet.
    Huesch MD
    JAMA; 2014 Mar; 311(12):1203-4. PubMed ID: 24668099
    [No Abstract]   [Full Text] [Related]  

  • 30. Family physician attitudes about prescribing using a drug formulary.
    Suggs LS; Raina P; Gafni A; Grant S; Skilton K; Fan A; Szala-Meneok K
    BMC Fam Pract; 2009 Oct; 10():69. PubMed ID: 19835601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experts' agency problems: evidence from the prescription drug market in Japan.
    Iizuka T
    Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 33. Physician Agency and Adoption of Generic Pharmaceuticals.
    Iizuka T
    Am Econ Rev; 2012 Oct; 102(6):2826-58. PubMed ID: 29522299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How vertical integration affects the quantity and cost of care for Medicare beneficiaries.
    Koch TG; Wendling BW; Wilson NE
    J Health Econ; 2017 Mar; 52():19-32. PubMed ID: 28182998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicians. Profiling in practice.
    Montague J
    Hosp Health Netw; 1994 Jan; 68(2):50-1. PubMed ID: 8275129
    [No Abstract]   [Full Text] [Related]  

  • 36. Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study.
    Mondelo-García C; Mendoza E; Movilla-Fernández MJ; Coronado C
    Health Policy; 2018 Dec; 122(12):1316-1325. PubMed ID: 30201184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of therapeutic alternatives: physicians' knowledge.
    Griswold MW; Briceland LL; Lesar TS
    Ann Pharmacother; 1996; 30(7-8):882-3. PubMed ID: 8826578
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care costs in a declining America.
    de Lorimier AA
    J Pediatr Surg; 1993 Mar; 28(3):281-91. PubMed ID: 8468634
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationship of antidepressant prescribing concentration to treatment duration and cost.
    Hodgkin D; Merrick EL; Hiatt D
    J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.